Category Archive for: ‘Blog’

37 Patients in New Jersey Develop Infections after Receiving Pain-Relief Injections

Knee Injection

Health officials in the State of New Jersey have reported that 37 patients who were treated with pain relief injections Monmouth County, NJ have developed infections. Upon investigation, state officials found several infection control and injection safety breaches at Osteo Relief Institute Jersey Shore which they are blaming for 31 cases of septic arthritis, a painful infection, that occured after …

Read More

FDA warns Pfizer Inc. of “significant violations” at a manufacturing plant


Last month, the United States Food and Drug Administration sent a letter to pharmaceutiucal company, Pfizer, Inc., warning of “significant violations” at a Hospira manufacturing plant. Pfizer acquired Hospira in a $17 billion deal in 2015. An inspection was conducted from May to June of 2015 at a McPherson, Kansas Hospira drug plant, and the inspection cited “significant violations of …

Read More

Investigating unexpected death following a medical procedure.

One day before the 2017 Academy Awards, it was reported that actor Bill Paxton, only 61 years old, died of complications following heart surgery. His death was referenced throughout the awards ceremony and Hollywood paid an emotional tribute to Bill Paxton’s memory during an In Memoriam segment shown at the awards. There was little additional information provided regarding the actor’s …

Read More

Children’s Hospital of Philadelphia funded by FDA to study possible neurological effects of MiriLAX on children under seventeen

Miralax Logo

Since 2014, the Children’s Hospital of Philadelphia (CHOP) has been conducting a study, funded by the FDA, on the disturbing effects of over-the-counter laxative, MiraLAX, on children. The hospital refuses to release any information on the study or the individual families involved until it is concluded. The study is surrounding a chemical found in MiraLAX powder called Polyethylene glycol 3350 …

Read More

Common over-the-counter meds possibly causing extreme neurological changes in children

Miralax Long 1

A study currently underway at the Children’s Hopsital of Philadelphia (CHOP) is trying to determine whether MiraLAX, a common over-the-counter treatment for constipation, is responsible for extreme neuro-psychiatric problems in children under 17 who have treated with the drug. According to a number of families who spoke with Action News (WPVI-6) in Philadelphia, children underwent rapid and disturbing changes to …

Read More

Page 1 of 5912345»102030...Last »

Philadelphia | Downingtown | Conshohocken | Cherry Hill | Collingswood | Linwood | Roselle